COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

A Bartoli, F Gabrielli, T Alicandro, F Nascimbeni… - Internal and emergency …, 2021 - Springer
Since its outbreak in China in December 2019 a novel Coronavirus, named SARS-CoV-2,
has spread worldwide causing many cases of severe pneumonia, referred to as COVID-19 …

[HTML][HTML] Therapeutic options for COVID-19: a review

R Pujari, MV Thommana, BR Mercedes, A Serwat - Cureus, 2020 - ncbi.nlm.nih.gov
An acute respiratory disease caused by a novel coronavirus [severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), previously known as 2019-nCoV], the coronavirus …

Pharmacological treatments of COVID-19

A Sahebnasagh, R Avan, F Saghafi… - Pharmacological …, 2020 - Springer
The viral infection due to the new coronavirus or coronavirus disease 2019 (COVID-19),
which was reported for the first time in December 2019, was named by the World Health …

Current drugs with potential for treatment of COVID-19: A literature review: Drugs for the treatment process of COVID-19

MII Rabby - Journal of pharmacy & pharmaceutical …, 2020 - journals.library.ualberta.ca
Purpose: SARS-CoV-2 first emerged in China in December 2019 and rapidly spread
worldwide. No vaccine or approved drug is available to eradicate the virus, however, some …

COVID-19: A review of the proposed pharmacological treatments

S Lam, A Lombardi, A Ouanounou - European journal of pharmacology, 2020 - Elsevier
The emerging pandemic of coronavirus disease 2019 (COVID-19) caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented …

Drugs for COVID-19: An update

J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
The new type of coronavirus (COVID-19), SARS-CoV-2 originated from Wuhan, China and
has led to a worldwide pandemic. COVID-19 is a novel emerging infectious disease caused …

Systematic review on the therapeutic options for COVID-19: clinical evidence of drug efficacy and implications

AR Abubakar, IH Sani, B Godman… - Infection and drug …, 2020 - Taylor & Francis
Abstract A novel coronavirus-2 (SARS-CoV-2) was first identified in Wuhan, China, and
quickly spread globally. Several treatments have been proposed, many of which have …

Advances in the possible treatment of COVID-19: A review.

P Chibber, SA Haq, I Ahmed, NI Andrabi… - European journal of …, 2020 - Elsevier
The emergence of the global pandemic caused by novel severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has put a challenge to identify or derive the therapeutics for its …

An update on current therapeutic drugs treating COVID-19

R Wu, L Wang, HCD Kuo, A Shannar, R Peter… - Current pharmacology …, 2020 - Springer
The current pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has presented unprecedented …